-transparent.png){kind=logo}
In 11 patients suffering from medium to severe heart failure, we performed a clinical and instrumental study to evaluate the effectiveness of ubidecarenone (60 mg/die in a single oral dose), in addition to conventional treatment with digitalis and diuretics. After an 8-month follow-up in most patients we observed a significant improvement in clinical symptoms and in quality of life. Furthermore we were able to demonstrate a statistically significant decrease in left atrium dimensions (p less than 0.01), end-diastolic (p less than 0.01) and end-systolic (p less than 0.05) left ventricular diameters and a significative reduction in the distance of the septum from the e point of the mitral valve (p less than 0.05), expression of significant improvement of cardiac output.
P L Topi, and
A Davini, and
G Squarcini
January 1983,
Terapevticheskii arkhiv,
P L Topi, and
A Davini, and
G Squarcini
January 2001,
Terapevticheskii arkhiv,
P L Topi, and
A Davini, and
G Squarcini
March 1986,
Bollettino chimico farmaceutico,
P L Topi, and
A Davini, and
G Squarcini
January 2003,
Klinicheskaia meditsina,
P L Topi, and
A Davini, and
G Squarcini
January 1991,
Revue neurologique,
P L Topi, and
A Davini, and
G Squarcini
January 2004,
Roczniki Akademii Medycznej w Bialymstoku (1995),
P L Topi, and
A Davini, and
G Squarcini
February 1967,
Klinicheskaia meditsina,
P L Topi, and
A Davini, and
G Squarcini
March 1970,
Voenno-meditsinskii zhurnal,
P L Topi, and
A Davini, and
G Squarcini
January 2022,
Computational and mathematical methods in medicine,
P L Topi, and
A Davini, and
G Squarcini
March 1962,
Sovetskaia meditsina,
